CN Patent

CN120322224A — 雌激素受体拮抗剂的剂型

Assigned to Olema Pharmaceuticals Inc · Expires 2025-07-15 · 1y expired

What this patent protects

本公开提供了单位剂型，所述单位剂型包含化合物1：或其药学上可接受的盐，所述单位剂型可用于治疗雌激素受体介导的疾病、病症和疾患。当前描述的单位剂型适合用于口服施用。

USPTO Abstract

本公开提供了单位剂型，所述单位剂型包含化合物1：或其药学上可接受的盐，所述单位剂型可用于治疗雌激素受体介导的疾病、病症和疾患。当前描述的单位剂型适合用于口服施用。

Drugs covered by this patent

Patent Metadata

Patent number: CN120322224A
Jurisdiction: CN
Classification: —
Expires: 2025-07-15
Drug substance claim: No
Drug product claim: No
Assignee: Olema Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.